Celyad SA Cash Flow Conversion Efficiency

Latest as of December 2024: 0.177x

Celyad SA cash flow conversion efficiency. Based on the latest financial reports, Celyad SA (CYAD) has a cash flow conversion efficiency ratio of 0.177x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.85 Million ≈ $-3.33 Million USD) by net assets (€-16.12 Million ≈ $-18.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Celyad SA (2010–2024)

Cash flow conversion efficiency of Celyad SA from 2010 to 2024. This chart illustrates how Celyad SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CYAD live share price for real-time trading data and today's change.

Celyad SA Cash Flow Conversion Ratio Explained

Celyad SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Celyad SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celyad SA ranked by their cash flow conversion efficiency. Also see Celyad SA (CYAD) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hawsons Iron Ltd AU:HIO	-0.015x
Jwwinvest WAR:JWW	0.098x
João Fortes Engenharia S.A. SA:JFEN3	0.152x
Morgan Advanced Materials plc LSE:MGAM	0.059x
Reliance Chemotex Industries Limited NSE:RELCHEMQ	0.161x
Australian Oilseeds Holdings Limited Ordinary Shares NASDAQ:COOT	0.427x
BAIYU Holdings Inc. NASDAQ:BYU	-0.009x
Atomo Diagnostics Ltd AU:AT1	-0.145x

Annual Cash Flow Conversion Efficiency for Celyad SA (2010–2024)

The table below shows the annual cash flow conversion efficiency of Celyad SA from 2010 to 2024. Review Celyad SA (CYAD) financial flexibility to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-16.12 Million ≈ $-18.85 Million	€-5.68 Million ≈ $-6.64 Million	0.352x	+114.61%
2023-12-31	€6.30 Million ≈ $7.37 Million	€-15.20 Million ≈ $-17.77 Million	-2.411x	+62.83%
2022-12-31	€4.32 Million ≈ $5.05 Million	€-28.01 Million ≈ $-32.75 Million	-6.488x	-962.73%
2021-12-31	€43.64 Million ≈ $51.02 Million	€-26.64 Million ≈ $-31.15 Million	-0.611x	+31.60%
2020-12-31	€30.99 Million ≈ $36.24 Million	€-27.66 Million ≈ $-32.34 Million	-0.893x	-44.38%
2019-12-31	€45.62 Million ≈ $53.33 Million	€-28.20 Million ≈ $-32.97 Million	-0.618x	-26.12%
2018-12-31	€55.59 Million ≈ $64.99 Million	€-27.25 Million ≈ $-31.86 Million	-0.490x	+52.97%
2017-12-31	€47.53 Million ≈ $55.57 Million	€-49.55 Million ≈ $-57.93 Million	-1.042x	-283.66%
2016-12-31	€90.88 Million ≈ $106.25 Million	€-24.69 Million ≈ $-28.87 Million	-0.272x	-10.92%
2015-12-31	€111.47 Million ≈ $130.32 Million	€-27.30 Million ≈ $-31.92 Million	-0.245x	+62.47%
2014-12-31	€26.68 Million ≈ $31.20 Million	€-17.41 Million ≈ $-20.36 Million	-0.653x	-3.66%
2013-12-31	€16.90 Million ≈ $19.76 Million	€-10.64 Million ≈ $-12.44 Million	-0.630x	-109.91%
2012-12-31	€-1.31 Million ≈ $-1.53 Million	€-8.34 Million ≈ $-9.75 Million	6.352x	+169.92%
2011-12-31	€840.11K ≈ $982.18K	€-7.63 Million ≈ $-8.92 Million	-9.084x	-848.39%
2010-12-31	€8.69 Million ≈ $10.16 Million	€-8.32 Million ≈ $-9.73 Million	-0.958x	--

About Celyad SA

BR:CYAD Belgium Biotechnology

Market Cap

$10.26 Million

€8.77 Million EUR

Market Cap Rank

#27221 Global

#104 in Belgium

Share Price

€0.20

Change (1 day)

-2.00%

52-Week Range

€0.17 - €0.50

All Time High

€54.05